An unloved company in an unloved sector | Recce Pharmaceuticals pops after positive trial
General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.
About this video
Shares of Recce Pharmaceuticals Ltd (RCE) have been going great after positive market updates about its phase one drug trial results. CEO James Graham joined us from Tampa, Florida, to talk about the pharmaceutical company and its products.
Graham says the company has seen an encouraging indication of what may be possible when looking into evident efficacy that would come into phase two.
More like this
4:51
Recce strengthens its patent armour14 July 20263:58
Market Update | Oil & Energy Stocks, Gold, Steadfast, Origin Energy, SK Hynix, Ryman Healthcare, Recce, Coronado Global Resources14 July 2026 · GMD, ORG, RYM, SDF52:34
the callthe call: 30th March | RCE ORA DUR VAU SFR 360 KPG IFL WEB SM130 Mar 2026 · 360, IFL, ORA, SFR0:56
Market Update | Pro Medicus, Insurance Australia Group, Credit Corp, Dyno Nobel, Worley, Caterpillar, RPM Global, Genesis Minerals, Virgin Australia, Austal, Bapcor, Harvey Norman, Activeport, Megaport, Recce Pharmaceuticals, 4D Medical1 Sept 2025 · 4DX, ASB, DNL, GMD